FOXA2 and colorectal carcinoma: As shown in Figure7A–D, sh‐FOXA2‐enhanced cellular and lipid ROS production was strongly diminished upon Nrf2 expression promotion induced by ML334 or the Nrf2 plasmid in OXA‐treated CRC cells.